Soligenix
SNGX
#10207
Rank
ยฃ9.21 M
Marketcap
ยฃ0.91
Share price
-0.81%
Change (1 day)
-49.01%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.43. In 2024 the company made an earnings per share (EPS) of -ยฃ3.73 an increase over its 2023 EPS that were of -ยฃ9.48.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-34.8%
2024-ยฃ3.73-60.66%
2023-ยฃ9.48-83.55%
2022-ยฃ57.6513.95%
2021-ยฃ50.59-56.03%
2020-ยฃ115.0633.33%
2019-ยฃ86.29-29.41%
2018-ยฃ122.25-41.38%
2017-ยฃ208.5424.73%
2016-ยฃ167.19-69%
2015-ยฃ539.32-6.25%
2014-ยฃ575.28-50.77%
2013-ยฃ1,16975.68%
2012-ยฃ665.1768.18%
2011-ยฃ395.50-69.86%
2010-ยฃ1,312-8.75%
2009-ยฃ1,43833.33%
2008-ยฃ1,079-57.14%
2007-ยฃ2,517-46.15%
2006-ยฃ4,67444.44%
2005-ยฃ3,236-40.7%
2004-ยฃ5,457-15.62%
2003-ยฃ6,468-25.52%
2002-ยฃ8,684-80.94%
2001-ยฃ45,559160.89%
2000-ยฃ17,463-40.57%
1999-ยฃ29,382-63.84%
1998-ยฃ81,258601.73%
1997-ยฃ11,580101.7%
1996-ยฃ5,741

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.34-443.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.02-141.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.55-163.74%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.52-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.93-138.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.06-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA